Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis


Kose K., Utaş S., Yazici C., Akdas A., Kelestimur F.

BRITISH JOURNAL OF DERMATOLOGY, vol.144, no.6, pp.1121-1126, 2001 (SCI-Expanded) identifier identifier

Abstract

Background T-cell activation has been implicated in the pathogenesis of psoriasis; adenosine deaminase (ADA) activity has been considered as a marker of T-cell activation. The antithyroid drug propylthiouracil (PTU) has recently been shown to have beneficial effects on psoriatic lesions, probably by acting on the immune system.